NCT00195559View on ClinicalTrials.gov

Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

526

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

December 31, 2007

Conditions

Premenstrual SyndromeMenstruation Disturbances

Interventions

DRUG

Levonorgestrel/Ethinyl Estradiol

Trial Locations (51)

Unknown

Buenos Aires

Córdoba

Rosario-Santa Fe

Curitiba

Goiânia

Porto Alegre

Salvador

São Paulo

Sorocaba

Santiago

Temuco

Aarhus

Frederiksberg

København NV

Rungsted Kyst

Helsinki

Kuopio

Oulu

Turku

Berlin

Bonn

Hamburg

Hanover

Lomas de Virreyes

Guadalajara

Zapopan

Monterrey

San Luis Potosí City

Mexico City

Amsterdam

Apeldoorn

Den Helder

Enschede

Nieuwegein

Bialystok

Gdansk

Mysłowice

Poznan

Warsaw

S, Bucharest

Cluj-Napoca

Iași

Gothenburg

Stockholm

Umeå

Uppsala

Conwell

Fowey

London

Plymouth

St Austell

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00195559 - Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder | Biotech Hunter | Biotech Hunter